The past two decades have brought a number of serious threats to public health in South Africa. One of these is the growing burden of non-communicable, chronic diseases. These diseases are already responsible for a large share of premature adult mortality and morbidity, and the burden they impose on the public sector health care system and national health budget is likely to grow substantially in coming years. HE2RO and its partner, Boston University, are developing a body of work to quantify the disease burden and economic impact of non-communicable diseases (NCDs) in South Africa and to estimate the costs and cost-effectiveness of different models and approaches to NCD care and treatment delivery. The results of this research will help inform policy makers, healthcare providers, and funding agencies of the potential cost of NCDs in the decades to come and the resources needed to address the NCD epidemic.
Low Prevalence of Depressive Symptoms among Stable Patients on Antiretroviral Therapy in Johannesburg, South AfricaDepression is a leading cause of morbidity worldwide. It affects more than 300 million individuals globally and depressive disorders are currently the 4th leading cause of Years Lived with Disability (YLD) in South Africa. People living with HIV are disproportionately affected by mental health disorders and while the lifetime prevalence of depression in the general population of South Africa is estimated as 9.7%, estimates from HIV-infected populations have ranged from 14-62%, with variability
Stay up to date
Receive newsletters and keep up to date with developments at HE2RO.